Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K-H Shu

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|February 8, 2012
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research databaseS-F Tsai, C-Y Cheng, K-H Shu, et al.
International Journal of Clinical Practice. Supplement|December 25, 2004
A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patientsP Y A Ding, K M Chu, H T Chiang, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|June 1, 1993
Primary IgA nephropathy: a nine-year clinicopathologic study in the Veterans General Hospital-TaichungS S Sheu, K H Shu, Y S Lu, et al.
Kidney International|August 1, 2000
Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathyK H Shu, S H Lee, C H Cheng, et al.
Transplantation Proceedings|August 1, 1992
Hypertension following successful renal transplantationK H Shu, J D Lian, Y S Lu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 14, 1997
Another simpler bypassing dialysate technique for measuring post-haemodialysis BUNM J Wu, Y F Feng, K H Shu, et al.
Transplantation Proceedings|October 15, 2018
Clinical Significance of Serum Visfatin in Renal Transplant RecipientsK-H Shu, H-F Chiu, M-J Wu, et al.
Transplantation Proceedings|December 20, 2000
MMF-based regimen in maintenance therapy after kidney transplantationM J Wu, K H Shu, C H Cheng, et al.
Clinical Nephrology|July 23, 2004
Risk factors for peptic ulcer disease in renal transplant patients--11 years of experience from a single centerK J Chen, C H Chen, C H Cheng, et al.
Transplantation Proceedings|September 16, 2008
Possible mechanism by which rapamycin increases cyclosporine nephrotoxicityC-H Cheng, H-R Chang, C-W Chiang, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|February 8, 2012
Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research databaseS-F Tsai, C-Y Cheng, K-H Shu, et al.
International Journal of Clinical Practice. Supplement|December 25, 2004
A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patientsP Y A Ding, K M Chu, H T Chiang, et al.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed|June 1, 1993
Primary IgA nephropathy: a nine-year clinicopathologic study in the Veterans General Hospital-TaichungS S Sheu, K H Shu, Y S Lu, et al.
Kidney International|August 1, 2000
Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathyK H Shu, S H Lee, C H Cheng, et al.
Transplantation Proceedings|August 1, 1992
Hypertension following successful renal transplantationK H Shu, J D Lian, Y S Lu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 14, 1997
Another simpler bypassing dialysate technique for measuring post-haemodialysis BUNM J Wu, Y F Feng, K H Shu, et al.
Transplantation Proceedings|October 15, 2018
Clinical Significance of Serum Visfatin in Renal Transplant RecipientsK-H Shu, H-F Chiu, M-J Wu, et al.
Transplantation Proceedings|December 20, 2000
MMF-based regimen in maintenance therapy after kidney transplantationM J Wu, K H Shu, C H Cheng, et al.
Clinical Nephrology|July 23, 2004
Risk factors for peptic ulcer disease in renal transplant patients--11 years of experience from a single centerK J Chen, C H Chen, C H Cheng, et al.
Transplantation Proceedings|September 16, 2008
Possible mechanism by which rapamycin increases cyclosporine nephrotoxicityC-H Cheng, H-R Chang, C-W Chiang, et al.
Pageof 10